{"author_name":null,"author_url":null,"height":"300","html":"\r\n\r\n\r\n
\r\n\t\r\n\t
\r\n\t\t
\r\n\t\t\tPosted 6\/7\/2019<\/span><\/small>\r\n\t\t\t\r\n\t\t\t\tPromising Results In Study Assessing CBD For Dogs With Epilepsy by Dr. Stephanie McGrath\r\n\t\t\t\t<\/i>\r\n\t\t\t<\/a>\r\n\t\t\t\r\n\t\t\t\t<\/i>\r\n\t\t\t<\/a>\r\n\t\t<\/div>\r\n\t\t
Dr. Stephanie McGrath, a neurologist at Colorado State University’s James L. Voss Veterinary Teaching Hospital, has revealed initial findings from a groundbreaking study to assess the use of cannabidiol, or CBD, for dogs with epilepsy. Based on her research, she found that 89 percent of dogs who received CBD in a clinical trial had a reduction in the frequency of seizures. “Overall, what we found seems very promising,” she said.<\/div>\r\n\t<\/div>\r\n<\/div>\r\n","thumbnail_url":"https:\/\/www.whoswhoincannabis.com\/image\/morningcoffeelinklogo","title":null,"type":"rich","version":"1.0","width":"320"}